FDA Regulation and the New Anti-aging Products

FDA Regulation and the New Anti-aging Products

DSpace/Manakin Repository

FDA Regulation and the New Anti-aging Products

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Hensel, Donald P.
dc.date.accessioned	2012-06-07T01:57:41Z
dc.date.issued	1995
dc.identifier.citation	Donald P. Hensel, FDA Regulation and the New Anti-aging Products (1995).	en_US
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846730
dc.description.abstract	In the decades since the enactment of the Federal Food, Drug, and Cosmetic Act (the "Act")' in 1938, one of the more persistent challenges facing the Food and Drug Administration (the "FDA") has been to apply an old statute to the regulatory problems generated by new technologies. The development of new anti-aging skin preparations is a recent example of this phenomenon. Although potions purporting to make the skin younger have existed for centuries, today's youth-seekers are spending billions on new products that just might work. In particular, the development of alpha hydroxy acids ("AHAs") has been promising. Derived from fruit, sugar cane, and milk, AHAs cause the surface layer of dead skin cells to shed, hastening the appearance of fresh cells. The laboratory results are inconclusive thus far, but preliminary research shows that some products may deliver active ingredients to the skin's inner layer, stimulating the production of moisturizing acids and cells such as collagen that help to keep the skin firm.	en_US
dc.language.iso	en_US	en
dash.license	LAA
dc.subject	Food and Drug Law	en_US
dc.subject	alpha hydroxy acids	en_US
dc.subject	AHAs	en_US
dc.subject	AHA	en_US
dc.subject	third-year paper	en_US
dc.title	FDA Regulation and the New Anti-aging Products	en_US
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-07T01:57:41Z